Search Results - Bi-Cheng Liu

Refine Results
  1. 1

    Extracellular Vesicles: Opportunities and Challenges for the Treatment of Renal Diseases by Tao-Tao Tang, Lin-Li Lv, Hui-Yao Lan, Bi-Cheng Liu

    Published in Frontiers in Physiology (2019-03-01)
    Get full text
    Article


  2. 2

    Current understanding of sodium-glucose transporter 2 inhibitors in cardiovascular-kidney-metabolic syndrome by Yan Yang, Wen Zhou, Min Yang, Sydney C. W. Tang, Bi-Cheng Liu

    Published in Frontiers in Pharmacology (2026-04-01)
    Get full text
    Article


  3. 3

    An update on renal fibrosis: from mechanisms to therapeutic strategies with a focus on extracellular vesicles by Cui Wang, Shang-Wei Li, Xin Zhong, Bi-Cheng Liu, Lin-Li Lv

    Published in Kidney Research and Clinical Practice (2023-03-01)
    Get full text
    Article


  4. 4

    HIPK2 C-terminal domain inhibits NF-κB signaling and renal inflammation in kidney injury by Ye Feng, Zhengzhe Li, Heather Wang, Bi-Cheng Liu, Kyung Lee, John Cijiang He

    Published in JCI Insight (2024-04-01)
    Get full text
    Article


  5. 5

    Shedding light on the role of extracellular vesicles in renal fibrosis by Tao-Tao Tang, Yi-Lin Zhang, Steven D. Crowley, Lin-Li Lv, Bi-Cheng Liu

    Published in Fundamental Research (2026-03-01)
    Get full text
    Article


  6. 6

    Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation by Jing-Yuan Cao, Le-Ting Zhou, Zuo-Lin Li, Yan Yang, Bi-Cheng Liu, Hong Liu

    Published in Journal of Pharmacological Sciences (2020-07-01)
    Get full text
    Article


  7. 7

    Renal tubular epithelial cells response to injury in acute kidney injury by Zuo-Lin Li, Xin-Yan Li, Yan Zhou, Bin Wang, Lin-Li Lv, Bi-Cheng Liu

    Published in EBioMedicine (2024-09-01)
    Get full text
    Article


  8. 8

    Cardiorenal protection of SGLT2 inhibitors—Perspectives from metabolic reprogramming by Yue-Ming Gao, Song-Tao Feng, Yi Wen, Tao-Tao Tang, Bin Wang, Bi-Cheng Liu

    Published in EBioMedicine (2022-09-01)
    Get full text
    Article


  9. 9

    mRNA therapy: A new frontier in regenerative medicine by Ding‐Ding Xue, Yue Zhang, An‐Ran Shen, Tao‐Tao Tang, Bi‐Cheng Liu, Lin‐Li Lv

    Published in Interdisciplinary Medicine (2025-03-01)
    Get full text
    Article


  10. 10

    Combination of a Novel Genetic Variant in CFB Gene and a Pathogenic Variant in COL4A5 Gene in a Sibling Renal Disease: A Case Report by Feng-mei Wang, Yan Yang, Xiao-liang Zhang, Yan-li Wang, Yan Tu, Bi-Cheng Liu, Bin Wang

    Published in Frontiers in Genetics (2021-07-01)
    Get full text
    Article


  11. 11

    WCN24-1016 MINCLE RECEPTOR IN MACROPHAGE AND NEUTROPHIL CONTRIBUTES TO THE UNRESOLVED INFLAMMATION DURING THE TRANSITION FROM AKI TO CKD by Cui Wang, Yi-Lin Zhang, An-Ran Shen, Ning Li, Chuan-Hui Xu, Bi-Cheng Liu, Lin-Li Lv

    Published in Kidney International Reports (2024-04-01)
    Get full text
    Article


  12. 12

    Effects of Sacubitril/Valsartan on resistant hypertension and myocardial work in hemodialysis patients by Bin Wang, Gui‐hua Wang, Xiu‐xia Ding, Hai‐xia Tang, Jing Zheng, Bi‐cheng Liu, Xiao‐liang Zhang

    Published in The Journal of Clinical Hypertension (2022-03-01)
    Get full text
    Article


  13. 13

    Roxadustat on Renal Anemia with Macroinflammation: A Retrospective Cohort Study by Yan Tu, Zuo-Lin Li, Hong Liu, Ri-Ning Tang, Gui-Hua Wang, Lin-Li Lv, Bin Wang, Bi-Cheng Liu

    Published in Kidney Diseases (2024-03-01)
    Get full text
    Article


  14. 14

    Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of Chronic Kidney Disease by Le-Ting Zhou, Shen Qiu, Lin-Li Lv, Zuo-Lin Li, Hong Liu, Ri-Ning Tang, Kun-Ling Ma, Bi-Cheng Liu

    Published in Kidney & Blood Pressure Research (2018-04-01)
    Get full text
    Article


  15. 15

    Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis. by Le-Ting Zhou, Lin-Li Lv, Ming-Ming Pan, Yu-Han Cao, Hong Liu, Ye Feng, Hai-Feng Ni, Bi-Cheng Liu

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  16. 16

    Fibrinogen-to-albumin ratio is related to the severity of coronary artery disease in chronic kidney disease patients undergoing coronary angiography by Li-Hua Lin, Hong Liu, Dong-Hua Jin, Jun Zou, Yu-Xian Xie, Hong Qiu, Miao Jia, Da-Mei Li, Bi-Cheng Liu

    Published in Nefrología (2022-11-01)
    Get full text
    Article


  17. 17

    Fibrinogen-to-albumin ratio is related to the severity of coronary artery disease in chronic kidney disease patients undergoing coronary angiography by Li-Hua Lin, Hong Liu, Dong-Hua Jin, Jun Zou, Yu-Xian Xie, Hong Qiu, Miao Jia, Da-Mei Li, Bi-Cheng Liu

    Published in Nefrología (English Edition) (2022-11-01)
    Get full text
    Article


  18. 18

    The Roxadustat (FG-4592) ameliorates tubulointerstitial fibrosis by promoting intact FGF23 cleavage by Jing Wang, Zuo-Lin Li, Yan Zhou, Zhong-Tang Li, Yan Tu, Xin-Hui Hu, Jin-Hua Zhu, Bi-Cheng Liu, Hong Liu

    Published in Cell Communication and Signaling (2025-04-01)
    Get full text
    Article


  19. 19

    Correction: Inflammation Disrupts the LDL Receptor Pathway and Accelerates the Progression of Vascular Calcification in ESRD Patients. by Jing Liu, Kun Ling Ma, Min Gao, Chang Xian Wang, Jie Ni, Yang Zhang, Xiao Liang Zhang, Hong Liu, Yan Li Wang, Bi Cheng Liu

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  20. 20

    Inflammation disrupts the LDL receptor pathway and accelerates the progression of vascular calcification in ESRD patients. by Jing Liu, Kun Ling Ma, Min Gao, Chang Xian Wang, Jie Ni, Yang Zhang, Xiao Liang Zhang, Hong Liu, Yan Li Wang, Bi Cheng Liu

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


Search Tools: